• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

热休克蛋白70(HSP70)抑制可逆转多发性骨髓瘤中细胞黏附介导的及获得性耐药。

HSP70 inhibition reverses cell adhesion mediated and acquired drug resistance in multiple myeloma.

作者信息

Nimmanapalli Ramadevi, Gerbino Elvira, Dalton William S, Gandhi Varsha, Alsina Melissa

机构信息

Department of Pathobiology, College of Veterinary Medicine, Tuskegee University, Tuskegee, AL 36088, USA.

出版信息

Br J Haematol. 2008 Aug;142(4):551-61. doi: 10.1111/j.1365-2141.2008.07217.x. Epub 2008 May 22.

DOI:10.1111/j.1365-2141.2008.07217.x
PMID:18503584
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4503206/
Abstract

Heat shock proteins (HSPs) are a super family of highly conserved molecular chaperone proteins, which are induced in response to stress. HSP70 has been demonstrated to inhibit apoptosis induced by a number of chemotherapeutic agents. Previous investigations have suggested the development of drug resistance in multiple myeloma (MM) cells after adhesion to stroma. This study used MM cell lines and primary plasma cells to determine if HSP70 had a role in development of chemo resistance. Adhesion of MM cells to either bone marrow stromal cells or fibronectin (FN) enhanced HSP70 expression. Inhibition of the HSP70 expression decreased 8226 cell adhesion to stroma or FN and induced more apoptosis in FN-adhered 8226 cells than in suspension cultures at 24 h. Further, HSP70 inhibitors enhanced melphalan-induced apoptosis and reversed melphalan-induced cell adhesion-mediated drug resistance (CAM-DR) phenotype. In addition, compared to parental cells, KNK-437, a heat shock factor inhibitor caused more apoptosis in melphalan-resistant 8226/LR5 cells and sensitized them to melphalan. Primary CD138 positive cells showed high expression of HSPA4 mRNA, and KNK-437 caused apoptosis in these cells. In conclusion, our data suggest inhibition of HSP70, reduced adhesion and caused apoptosis of both acquired and de novo drug resistant MM cells.

摘要

热休克蛋白(HSPs)是一类高度保守的分子伴侣蛋白超家族,其在应激反应中被诱导产生。HSP70已被证明可抑制多种化疗药物诱导的细胞凋亡。先前的研究表明,多发性骨髓瘤(MM)细胞黏附于基质后会产生耐药性。本研究使用MM细胞系和原代浆细胞来确定HSP70在化疗耐药性形成中是否起作用。MM细胞与骨髓基质细胞或纤连蛋白(FN)的黏附增强了HSP70的表达。抑制HSP70的表达可降低8226细胞与基质或FN的黏附,并在24小时时诱导FN黏附的8226细胞比悬浮培养的细胞发生更多凋亡。此外,HSP70抑制剂增强了美法仑诱导的细胞凋亡,并逆转了美法仑诱导的细胞黏附介导的耐药性(CAM-DR)表型。此外,与亲代细胞相比,热休克因子抑制剂KNK-437在美法仑耐药的8226/LR5细胞中引起更多凋亡,并使它们对美法仑敏感。原代CD138阳性细胞显示HSPA4 mRNA高表达,且KNK-437在这些细胞中引起凋亡。总之,我们的数据表明,抑制HSP70可减少黏附,并导致获得性和原发性耐药MM细胞凋亡。

相似文献

1
HSP70 inhibition reverses cell adhesion mediated and acquired drug resistance in multiple myeloma.热休克蛋白70(HSP70)抑制可逆转多发性骨髓瘤中细胞黏附介导的及获得性耐药。
Br J Haematol. 2008 Aug;142(4):551-61. doi: 10.1111/j.1365-2141.2008.07217.x. Epub 2008 May 22.
2
Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model.在同基因多发性骨髓瘤细胞系模型中对新生和获得性美法仑耐药性的基因型和表型比较。
Cancer Res. 2003 Nov 15;63(22):7900-6.
3
Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines.细胞黏附介导的耐药性(CAM-DR):整合素的作用及人骨髓瘤细胞系对凋亡的抗性
Blood. 1999 Mar 1;93(5):1658-67.
4
The FA/BRCA pathway is involved in melphalan-induced DNA interstrand cross-link repair and accounts for melphalan resistance in multiple myeloma cells.FA/BRCA通路参与美法仑诱导的DNA链间交联修复,并导致多发性骨髓瘤细胞对美法仑耐药。
Blood. 2005 Jul 15;106(2):698-705. doi: 10.1182/blood-2004-11-4286. Epub 2005 Mar 31.
5
Role of Myeloma-Derived MIF in Myeloma Cell Adhesion to Bone Marrow and Chemotherapy Response.骨髓瘤来源的巨噬细胞移动抑制因子在骨髓瘤细胞黏附于骨髓及化疗反应中的作用
J Natl Cancer Inst. 2016 Jul 5;108(11). doi: 10.1093/jnci/djw131. Print 2016 Nov.
6
Integrin β7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion.整合素β7 介导的多发性骨髓瘤细胞黏附、迁移和侵袭的调控。
Blood. 2011 Jun 9;117(23):6202-13. doi: 10.1182/blood-2010-06-292243. Epub 2011 Apr 7.
7
Tipifarnib and bortezomib are synergistic and overcome cell adhesion-mediated drug resistance in multiple myeloma and acute myeloid leukemia.替匹法尼和硼替佐米具有协同作用,可克服多发性骨髓瘤和急性髓性白血病中细胞黏附介导的耐药性。
Clin Cancer Res. 2006 Jan 15;12(2):591-9. doi: 10.1158/1078-0432.CCR-05-1792.
8
An inverse switch in DNA base excision and strand break repair contributes to melphalan resistance in multiple myeloma cells.DNA 碱基切除和链断裂修复的反向开关导致多发性骨髓瘤细胞对美法仑耐药。
PLoS One. 2013;8(2):e55493. doi: 10.1371/journal.pone.0055493. Epub 2013 Feb 6.
9
Monitoring a nuclear factor-κB signature of drug resistance in multiple myeloma.监测多发性骨髓瘤中药物耐药的核因子-κB 特征。
Mol Cell Proteomics. 2011 Nov;10(11):M110.005520. doi: 10.1074/mcp.M110.005520. Epub 2011 Aug 16.
10
Bcl-2 overexpression is associated with resistance to dexamethasone, but not melphalan, in multiple myeloma cells.在多发性骨髓瘤细胞中,Bcl-2的过表达与对地塞米松的耐药性相关,但与美法仑的耐药性无关。
Int J Oncol. 1998 Aug;13(2):397-405. doi: 10.3892/ijo.13.2.397.

引用本文的文献

1
Pathways to therapy resistance: The sheltering effect of the bone marrow microenvironment to multiple myeloma cells.治疗耐药途径:骨髓微环境对多发性骨髓瘤细胞的庇护作用。
Heliyon. 2024 Jun 14;10(12):e33091. doi: 10.1016/j.heliyon.2024.e33091. eCollection 2024 Jun 30.
2
CK1δ and CK1ε Signaling Sustains Mitochondrial Metabolism and Cell Survival in Multiple Myeloma.CK1δ 和 CK1ε 信号维持多发性骨髓瘤中的线粒体代谢和细胞存活。
Cancer Res. 2023 Dec 1;83(23):3901-3919. doi: 10.1158/0008-5472.CAN-22-2350.
3
Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases?在血液肿瘤疾病中,HSP70 仍然可以作为治疗靶点吗?
Biomolecules. 2023 Mar 28;13(4):604. doi: 10.3390/biom13040604.
4
Autophagy, molecular chaperones, and unfolded protein response as promoters of tumor recurrence.自噬、分子伴侣与未折叠蛋白反应作为肿瘤复发的促进因素
Cancer Metastasis Rev. 2023 Mar;42(1):217-254. doi: 10.1007/s10555-023-10085-3. Epub 2023 Feb 1.
5
Looking into Endoplasmic Reticulum Stress: The Key to Drug-Resistance of Multiple Myeloma?深入探究内质网应激:多发性骨髓瘤耐药的关键?
Cancers (Basel). 2022 Oct 29;14(21):5340. doi: 10.3390/cancers14215340.
6
Toll-like receptor 4 selective inhibition in medullar microenvironment alters multiple myeloma cell growth.Toll 样受体 4 选择性抑制骨髓微环境可改变多发性骨髓瘤细胞的生长。
Blood Adv. 2022 Jan 25;6(2):672-678. doi: 10.1182/bloodadvances.2020003704.
7
The heat shock response and small molecule regulators.热休克反应与小分子调节剂。
Eur J Med Chem. 2021 Dec 15;226:113846. doi: 10.1016/j.ejmech.2021.113846. Epub 2021 Sep 13.
8
Blockade of HSP70 by VER-155008 synergistically enhances bortezomib-induced cytotoxicity in multiple myeloma.阻断 HSP70 表达的 VER-155008 与硼替佐米联合应用可增强多发性骨髓瘤的细胞毒作用。
Cell Stress Chaperones. 2020 Mar;25(2):357-367. doi: 10.1007/s12192-020-01078-0. Epub 2020 Feb 6.
9
Proteometabolomics of Melphalan Resistance in Multiple Myeloma.多发性骨髓瘤中美法仑耐药的蛋白质代谢组学
Methods Mol Biol. 2019;1996:273-296. doi: 10.1007/978-1-4939-9488-5_21.
10
NRF2 Is One of the Players Involved in Bone Marrow Mediated Drug Resistance in Multiple Myeloma.NRF2 是多发性骨髓瘤骨髓介导的药物耐药性中的一个参与者。
Int J Mol Sci. 2018 Nov 7;19(11):3503. doi: 10.3390/ijms19113503.

本文引用的文献

1
Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin.废除热休克蛋白70的诱导作为一种增加热休克蛋白90抑制剂17-烯丙基氨基-去甲氧基格尔德霉素抗白血病活性的策略。
Cancer Res. 2005 Nov 15;65(22):10536-44. doi: 10.1158/0008-5472.CAN-05-1799.
2
Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model.在同基因多发性骨髓瘤细胞系模型中对新生和获得性美法仑耐药性的基因型和表型比较。
Cancer Res. 2003 Nov 15;63(22):7900-6.
3
Identification of genes modulated in multiple myeloma using genetically identical twin samples.利用基因相同的双胞胎样本鉴定多发性骨髓瘤中被调控的基因。
Blood. 2004 Mar 1;103(5):1799-806. doi: 10.1182/blood-2003-02-0402. Epub 2003 Sep 11.
4
Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia.白血病细胞VLA-4与基质纤连蛋白之间的相互作用是急性髓性白血病微小残留病的决定性因素。
Nat Med. 2003 Sep;9(9):1158-65. doi: 10.1038/nm909. Epub 2003 Aug 3.
5
Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms.骨髓基质衍生的可溶性因子和直接细胞接触通过不同机制促成骨髓瘤细胞的获得性耐药。
Leukemia. 2003 Jun;17(6):1175-82. doi: 10.1038/sj.leu.2402924.
6
HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway.热休克蛋白70作为Toll样受体/白细胞介素-1受体信号通路的内源性刺激物。
J Biol Chem. 2002 Apr 26;277(17):15107-12. doi: 10.1074/jbc.M111204200. Epub 2002 Feb 12.
7
Mechanisms associated with cell adhesion mediated drug resistance (CAM-DR) in hematopoietic malignancies.造血系统恶性肿瘤中与细胞黏附介导的耐药性(CAM-DR)相关的机制。
Cancer Metastasis Rev. 2001;20(1-2):43-50. doi: 10.1023/a:1013156407224.
8
Heat shock proteins 70 and 60 share common receptors which are expressed on human monocyte-derived but not epidermal dendritic cells.热休克蛋白70和60共享共同的受体,这些受体在人单核细胞衍生的细胞上表达,但不在表皮树突状细胞上表达。
Eur J Immunol. 2002 Feb;32(2):322-32. doi: 10.1002/1521-4141(200202)32:2<322::AID-IMMU322>3.0.CO;2-0.
9
Heat-shock protein 70 antagonizes apoptosis-inducing factor.热休克蛋白70拮抗凋亡诱导因子。
Nat Cell Biol. 2001 Sep;3(9):839-43. doi: 10.1038/ncb0901-839.
10
The effects of KNK437, a novel inhibitor of heat shock protein synthesis, on the acquisition of thermotolerance in a murine transplantable tumor in vivo.新型热休克蛋白合成抑制剂KNK437对小鼠体内可移植肿瘤耐热性获得的影响。
Clin Cancer Res. 2001 Jan;7(1):215-9.